NPI: 1710051123 · SHALLOTTE, NC 28470 · Family Medicine Physician · NPI assigned 11/17/2006
Authorized official WALTON, LEEA controls 20+ related entities in our dataset. Read more
| Authorized Official | WALTON, LEEA (RCS MANAGER) |
| NPI Enumeration Date | 11/17/2006 |
Other providers sharing the same authorized official: WALTON, LEEA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 15,913 | $368K |
| 2019 | 15,199 | $445K |
| 2020 | 10,042 | $407K |
| 2021 | 21,689 | $667K |
| 2022 | 33,120 | $674K |
| 2023 | 28,212 | $392K |
| 2024 | 23,622 | $67K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 26,671 | 23,629 | $1.79M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 11,139 | 9,680 | $577K |
| 99199 | Unlisted special service, procedure or report | 74,005 | 72,668 | $267K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 7,314 | 6,076 | $131K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3,447 | 1,614 | $45K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 2,535 | 1,949 | $43K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 520 | 501 | $32K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 846 | 744 | $24K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 413 | 381 | $24K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 286 | 227 | $23K |
| 99215 | Prolong outpt/office vis | 304 | 289 | $18K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,054 | 992 | $14K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 145 | 125 | $6K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 138 | 111 | $6K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 539 | 499 | $6K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 179 | 147 | $5K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 25 | 25 | $3K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 29 | 25 | $3K |
| 99201 | 64 | 47 | $2K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 301 | 254 | $1K |
| 87807 | 118 | 80 | $1K | |
| 81003 | 647 | 601 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 29 | 29 | $602.89 |
| 94060 | 54 | 54 | $364.90 | |
| 94726 | 53 | 53 | $247.10 | |
| 99406 | 29 | 29 | $245.83 | |
| 71046 | Radiologic examination, chest; 2 views | 31 | 31 | $214.19 |
| 94729 | 53 | 53 | $163.80 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 29 | 26 | $158.64 |
| 90734 | 24 | 15 | $147.84 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 19 | 16 | $111.98 |
| 90686 | 15 | 12 | $20.45 | |
| 90461 | 14 | 12 | $15.71 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 13 | 13 | $14.40 |
| 99173 | 18 | 14 | $2.04 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 3,558 | 3,340 | $0.00 |
| G8541 | Functional outcome assessment using a standardized tool not documented, reason not given | 3,298 | 3,079 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 445 | 415 | $0.00 |
| G8484 | Influenza immunization was not administered, reason not given | 670 | 619 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 254 | 239 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 98 | 90 | $0.00 |
| G9899 | Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed | 148 | 133 | $0.00 |
| 4040F | 88 | 85 | $0.00 | |
| 3023F | 106 | 103 | $0.00 | |
| 4004F | 14 | 12 | $0.00 | |
| G8598 | Aspirin or another antiplatelet therapy used | 13 | 12 | $0.00 |
| G8432 | Depression screening not documented, reason not given | 1,296 | 1,225 | $0.00 |
| G8536 | No documentation of an elder maltreatment screen, reason not given | 591 | 551 | $0.00 |
| 1036F | 1,382 | 1,289 | $0.00 | |
| G8732 | No documentation of pain assessment, reason not given | 2,680 | 2,506 | $0.00 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 802 | 757 | $0.00 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 267 | 255 | $0.00 |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 265 | 250 | $0.00 |
| 1123F | 76 | 73 | $0.00 | |
| 3017F | 326 | 308 | $0.00 | |
| G8926 | Spirometry test not performed or documented, reason not given | 176 | 172 | $0.00 |
| 1101F | 74 | 73 | $0.00 | |
| 92551 | 18 | 13 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 25 | 24 | $0.00 |
| G9717 | Documentation stating the patient has had a diagnosis of bipolar disorder | 27 | 25 | $0.00 |